Discovery of novel plasmodium falciparum pre-erythrocytic antigens for vaccine development

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Aguiar, Joao C ^a,b   Bolton, Jessica ^a,c   Wanga, Joyce ^a,d   Sacci, John B ^e   Iriko, Hideyuki ^f   Mazeika, Julie K ^a,g   Han, Eun Taek ^h   Limbach, Keith ^a,c   Patterso, Noelle B ^a,c   Sedegah, Martha ^a   Cruz, Ann Marie ⁱ   Tsuboi, Takafumi ^j   Hoffman, Stephen L ^k   Carucci, Daniel ^a   Hollingdale, Michael R ^a,c   Villasante, Eileen D ^a   Richie, Thomas L ^k  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Camris International   (United States)

^c Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

^d Technical Resources International Inc   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f KOBE UNIVERSITY   (Japan)

^g MILLIPORE CORPORATION   (United States)

^h Kangwon National University   (South Korea)

ⁱ United States of America PATH Malaria Vaccine Initiative ^*  (United States)

^j EHIME UNIVERSITY   (Japan)

^k SANARIA INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN; HYBRID PROTEIN; PLASMODIUM FALCIPARUM VACCINE; UNCLASSIFIED DRUG; VACCINE; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIGENICITY; ARTICLE; CELLULAR DISTRIBUTION; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHROCYTE; IMMUNE RESPONSE; IMMUNIZATION; LIVER CELL; MEROZOITE; MOLECULAR WEIGHT; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; SPOROZOITE; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; MALARIA, FALCIPARUM; MONONUCLEAR CELL; MOUSE; PARASITOLOGY; RABBIT;

ANIMALS; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HUMANS; IMMUNIZATION; LEUKOCYTES, MONONUCLEAR; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RABBITS; SPOROZOITES; T-LYMPHOCYTES;

EID: 84942915846     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136109     Document Type: Article

References (73)

1. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA. Genetic control of immunity to Plasmodium yoelii sporozoites. J Immunol. 1989; 143(12):4263-6. PMID: 2512354.
2. Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Cell. 1985; 42 (2):401-3. PMID: 2411417.
3. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979; 57 Suppl 1:165-73. PMID: 120766.
4. Clyde DF. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg. 1975; 24(3):397-401. PMID: 808142.
5. Rieckmann KH, Beaudoin RL, Cassells JS, Sell KW. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ. 1979; 57 Suppl 1:261-5. PMID: 120773.
6. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013; 341(6152):1359- 65. doi:10.1126/science.1241800 PMID: 23929949.
7. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009; 361(5):468-77. doi:10.1056/NEJMoa0805832PMID: 19641203.
8. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, et al. Long-term protection against malaria after experimental sporozoite inoculation: An open-label follow-up study. Lancet. 2011; 377(9779):1770-6. doi:10.1016/S0140-6736(11)60360-7 PMID: 21514658.
9. Khan SM, Janse CJ, Kappe SH, Mikolajczak SA. Genetic engineering of attenuated malaria parasites for vaccination. Current opinion in biotechnology. 2012; 23(6):908-16. doi:10.1016/j.copbio.2012.04.003 PMID: 22560204.
10. Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, et al. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine. 2013; 31(43):4975-83. doi:10.1016/j.vaccine.2013.08.007 PMID: 24029408.
11. Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins WE, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science. 1986; 232 (4752):881-4. PMID: 3085218.
12. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature. 2006; 444 (7121):937-40. PMID: 17151604.
13. Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. The Journal of experimental medicine. 1990; 171(3):763-73. PMID: 1689762.
14. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988; 85 (2):573-6. PMID: 2963334.
15. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of xirradiated sporozoites of plasmodium berghei. Nature. 1967; 216(5111):160-2. PMID: 6057225.
16. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 1989; 341(6240):323-6. PMID: 2477703.
17. Weiss WR, Jiang CG. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PloS one. 2012; 7(2):e31247. doi:10.1371/journal.pone.0031247PMID: 22355349.
18. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002; 185(8):1155-64. PMID: 11930326.
19. Lindner SE, Swearingen KE, Harupa A, Vaughan AM, Sinnis P, Moritz RL, et al. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Molecular & cellular proteomics: MCP. 2013; 12(5):1127-43.
20. Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, et al. Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N Engl J Med. 2013; 368(12):1111-20. doi:10.1056/NEJMoa1207564PMID: 23514288.
21. Moorthy VS, Ballou WR. Immunological mechanisms underlying protection mediated by RTS, S: A review of the available data. Malar J. 2009; 8(1):312.
22. Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Molecular microbiology. 2006; 59(5):1369-79. PMID: 16468982.
23. Bergmann-Leitner ES, Mease RM, De La Vega P, Savranskaya T, Polhemus M, Ockenhouse C, et al. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. PloS one. 2010; 5(8):e12294. doi:10.1371/journal.pone.0012294 PMID: 20808868.
24. Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science. 1991; 252 (5006):715-8. PMID: 1827210.
25. Robson KJ, Hall JR, Jennings MW, Harris TJ, Marsh K, Newbold CI, et al. A highly conserved aminoacid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature. 1988; 335(6185):79-82. PMID: 3045563.
26. Sanchez GI, Rogers WO, Mellouk S, Hoffman SL. Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites. Exp Parasitol. 1994; 79(1):59-62. PMID: 8050527.
27. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. The Journal of experimental medicine. 1996; 183 (4):1739-46. PMID: 8666931.
28. Moelans II, Meis JF, Kocken C, Konings RN, Schoenmakers JG. A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites. Mol Biochem Parasitol. 1991; 45(2):193-204. PMID: 2038355.
29. Fidock DA, Bottius E, Brahimi K, Moelans II, Aikawa M, Konings RN, et al. Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol Biochem Parasitol. 1994; 64(2):219-32. PMID: 7935600.
30. Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, et al. A liver-stagespecific antigen of Plasmodium falciparum characterized by gene cloning. Nature. 1987; 329 (6135):164-7. PMID: 3306406.
31. Zhu J, Hollingdale MR. Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol. 1991; 48(2):223-6. PMID: 1840628.
32. Mauduit M, Gruner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, et al. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PloS one. 2009; 4(11):e7717. doi:10.1371/journal.pone.0007717 PMID: 19890387.
33. Mishra S, Rai U, Shiratsuchi T, Li X, Vanloubbeeck Y, Cohen J, et al. Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine. 2011; 29(43):7335-42. doi:10.1016/j.vaccine.2011.07.081 PMID: 21807053.
34. Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol. 2000; 165(3):1453-62. PMID: 10903750.
35. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, et al. Live Attenuated Malaria Vaccine Designed to Protect through Hepatic CD8+ T Cell Immunity. Science. 2011; 334(6055):475-80. doi:10.1126/science.1211548PMID: 21903775.
36. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002; 419(6906):520-6. PMID: 12368866.
37. Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, et al. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Molecular & cellular proteomics: MCP. 2011; 10(9):M111007948.
38. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, Shatney L, et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A. 2003; 100(17):9952-7. PMID: 12886016.
39. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002; 419(6906):498-511. PMID: 12368864.
40. Doolan DL, Aguiar JC, Weiss WR, Sette A, Felgner PL, Regis DP, et al. Utilization of genomic sequence information to develop malaria vaccines. J Exp Biol. 2003; 206(Pt 21):3789-802. PMID: 14506214.
41. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics. 2008; 8(22):4680-94. doi:10.1002/pmic.200800194PMID: 18937256.
42. Sacci JB Jr., Ribeiro JM, Huang F, Alam U, Russell JA, Blair PL, et al. Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol Biochem Parasitol. 2005; 142(2):177-83. PMID: 15876462.
43. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci U S A. 2008; 105(1):305-10. doi:10.1073/pnas.0710780104PMID: 18172196.
44. Haddad D, Bilcikova E, Witney AA, Carlton JM, White CE, Blair PL, et al. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun. 2004; 72(3):1594-602. PMID: 14977966.
45. Albuquerque SS, Carret C, Grosso AR, Tarun AS, Peng X, Kappe SH, et al. Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics. 2009; 10:270. doi:10.1186/1471-2164-10-270 PMID: 19534804.
46. Aguiar JC, LaBaer J, Blair PL, Shamailova VY, Koundinya M, Russell JA, et al. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome research. 2004; 14 (10B):2076-82. PMID: 15489329.
47. Le Roch KG, Zhou Y, Blair PL, GraingerM, Moch JK, Haynes JD, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003; 301(5639):1503-8. PMID: 12893887.
48. Sedegah M, Charoenvit Y, Aguiar J, Sacci J, Hedstrom R, Kumar S, et al. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun. 2004; 5(7):553-61. PMID: 15318164.
49. Mehlin C, Boni E, Buckner FS, Engel L, Feist T, Gelb MH, et al. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol. 2006; 148(2):144-60. PMID: 16644028.
50. Vedadi M, Lew J, Artz J, Amani M, Zhao Y, Dong A, et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol. 2007; 151(1):100-10. PMID: 17125854.
51. Kolb VA, Makeyev EV, Spirin AS. Co-translational folding of an eukaryotic multidomain protein in a prokaryotic translation system. J Biol Chem. 2000; 275(22):16597-601. PMID: 10748063.
52. Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun. 2008; 76 (4):1702-8. doi:10.1128/IAI.01539-07 PMID: 18268027.
53. Arumugam TU, Ito D, Takashima E, Tachibana M, Ishino T, Torii M, et al. Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery. Expert Rev Vaccines. 2014; 13(1):75-85. doi:10.1586/14760584.2014.861747 PMID: 24308585.
54. Sawasaki T, Ogasawara T, Morishita R, Endo Y. A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci U S A. 2002; 99(23):14652-7. PMID: 12409616.
55. Wirtz RA, Zavala F, Charoenvit Y, Campbell GH, Burkot TR, Schneider I, et al. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ. 1987; 65(1):39-45. PMID: 3555879.
56. Sacci JB Jr., Alam U, Douglas D, Lewis J, Tyrrell DL, Azad AF, et al. Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol. 2006; 36(3):353- 60. PMID: 16442544.
57. Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, et al. Adenovirus 5-vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults. PloS one. 2011; 6(10):e24586. doi:10.1371/journal.pone.0024586 PMID: 22003383.
58. Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, et al. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J. 2011; 10:168. doi:10.1186/1475-2875-10-168PMID: 21689436.
59. Reece WH, Pinder M, Gothard PK, Milligan P, Bojang K, Doherty T, et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med. 2004; 10(4):406-10. PMID: 15034567.
60. Dunachie SJ, Walther M, Epstein JE, Keating S, Berthoud T, Andrews L, et al. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect Immun. 2006; 74(10):5933-42. PMID: 16988273.
61. Aikawa M, Cochrane AH, Nussenzweig RS, Rabbege J. Freeze-fracture study of malaria sporozoites: Antibody-induced changes of the pellicular membrane. J Protozool. 1979; 26(2):273-9. PMID: 385856.
62. Posthuma G, Meis JF, Verhave JP, Gigengack S, Hollingdale MR, Ponnudurai T, et al. Immunogold determination of Plasmodium falciparum circumsporozoite protein in Anopheles stephensi salivary gland cells. Eur J Cell Biol. 1989; 49(1):66-72. PMID: 2668001.
63. Bergmann-Leitner ES, Legler PM, Savranskaya T, Ockenhouse CF, Angov E. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS. Vaccine. 2011; 29(35):5940-9. doi:10.1016/j.vaccine.2011.06.053 PMID: 21722682.
64. Hollingdale MR, Leland P, Leef JL, Leef MF, Beaudoin RL. Serological reactivity of in vitro cultured exoerythrocytic stages of Plasmodium berghei in indirect immunofluorescent or immunoperoxidase antibody tests. Am J Trop Med Hyg. 1983; 32(1):24-30. PMID: 6337518.
65. Dunachie SJ, Walther M, Vuola JM, Webster DP, Keating SM, Berthoud T, et al. A clinical trial of primeboost immunisation with the candidate malaria vaccines RTS, S/AS02A and MVA-CS. Vaccine. 2006; 24(15):2850-9. PMID: 16434127.
66. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, et al. DNA prime/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PloS one. 2013; 8(2):1371.
67. Sedegah M, Kim D, Ganeshan H, Huang J, Belmonte M, Abot E, et al. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP). Malar J. 2013; 12:185. doi:10.1186/1475-2875-12-185 PMID: 23738590.
68. Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nature biotechnology. 2001; 19(3):242-7. PMID: 11231557.
69. Krzych U, Dalai S, Zarling S, Pichugin A. Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria. Frontiers in immunology. 2012; 3:370. doi:10.3389/fimmu.2012.00370 PMID: 23233854.
70. Calarota SA, Baldanti F. Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays. Clinical & developmental immunology. 2013; 2013:637649.
71. Limbach K, Aguiar J, Gowda K, Patterson N, Abot E, Sedegah M, et al. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates. Malar J. 2011; 10:65. doi:10.1186/1475-2875-10-65PMID: 21410955.
72. Rennenberg A, Lehmann C, Heitmann A, Witt T, Hansen G, Nagarajan K, et al. Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes. PLoS Pathog. 2010; 6(3):e1000825. doi:10.1371/journal.ppat.1000825PMID: 20361051.
73. Boysen KE, Matuschewski K. Inhibitor of cysteine proteases is critical for motility and infectivity of Plasmodium sporozoites. mBio. 2013; 4(6):e00874-13. doi:10.1128/mBio.00874-13PMID: 24281719.